Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...

Recursion Pharmaceuticals (RXRX) closed the most recent trading day at $3.85, moving -3.27% from the previous trading session. The stock's performance was behind the S&P 500's daily loss of 0.33%. On ...

THE prehistoric “super carnivore” megalodon was bigger than previously thought, growing to a whopping 80ft and weighing 94 tons. The beast would have been four times bigger than the largest great ...

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Tech company Nvidia designs and develops graphics processing units (GPUs) originally used for PC graphics and video games. Its GPUs are in high demand because they play a key role in training and ...

Saudi Aramco leads with a market cap of $1.65 trillion, distinct from others in the trillion-dollar club. ExxonMobil and Chevron follow, marking significant U.S. presence in global energy leadership.

Although battleships were replaced by aircraft carriers by the end of World War II, they remain a testament to a bygone era of warfare—and a symbol of their nations’ might. For nearly half a century, ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...